Phio Pharmaceuticals Corp. (PHIO) stock
PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.72−0.04 (-4.65%)
Close on Nov 17, 2026Market cap $8.33MP/E –Yield –
Phio Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Phio Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$12.20M. For fiscal 2025 it was -$7.98M. The highest annual figure on record is -$5.06M in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.98M | – |
| FY2024 | Dec 31, 2024 | -$7.11M | – |
| FY2023 | Dec 31, 2023 | -$10.75M | – |
| FY2022 | Dec 31, 2022 | -$12.13M | – |
| FY2021 | Dec 31, 2021 | -$11.86M | – |
| FY2020 | Dec 31, 2020 | -$8.80M | – |
| FY2019 | Dec 31, 2019 | -$8.65M | – |
| FY2018 | Dec 31, 2018 | -$7.52M | – |
| FY2017 | Dec 31, 2017 | -$9.51M | – |
| FY2016 | Dec 31, 2016 | -$7.76M | – |
| FY2015 | Dec 31, 2015 | -$7.32M | – |
| FY2014 | Dec 31, 2014 | -$7.76M | – |
| FY2013 | Dec 31, 2013 | -$6.31M | – |
| FY2012 | Dec 31, 2012 | -$5.06M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.04M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.00M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.08M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.09M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.54M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.28M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.37M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.95M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.01M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.37M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.90M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.77M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.71M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.71M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.53M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.43M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.47M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.47M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.87M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.26M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.27M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.62M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.97M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.03M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.18M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.55M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.99M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.93M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.18M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.75M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.01M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.86M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.91M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.20M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.20M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.32M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.80M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.37M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.60M | – |
See a number that looks wrong?